|
9th Influenza Conference 2023
Investigating the Antigenic Evolution of Influenza B Viruses and RSV
How respiratory viruses can change
|
9th Influenza Conference 2023
Best practices in vaccination programmes for risk groups and healthcare workers
SPI03 session from #ESWI2023
|
9th Influenza Conference 2023
Why influenza and RSV disease are a priority for policy makers
SPI01 session from #ESWI2023
|
9th Influenza Conference 2023
The bidirectional relationship between influenza and diabetes mellitus
The IDC partner symposium addressed questions like why influenza and diabetes are important to consider jointly; whether there is a bidirectional relationship; role of influenza vaccination on diabetes progression; how to improve vaccination uptake...
International scientific community gathers in Valencia for the 9th ESWI Conference on Influenza, COVID-19, and RSV
Since it was established 30 years ago, the European Scientific Working Group on Influenza and other Acute Respiratory Viruses (ESWI) is hosting the 9TH ESWI Influenza Conference
SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters
Two doses of COVID-19 mRNA vaccines in the primary series and a booster dose induce a strong antibody response, however, this response can be weak in people older than 80 years.
Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6
Although WHO has declared an end to the emergency phase of the COVID-19 pandemic, SARS-CoV-2 has continued to spread and evolve, giving rise to new variants.
Guidance for Developing a Sustainable Multistakeholder Immunization Coalition
Insights from immunization coalition experts and analysis of successful immunization coalitions
International Pediatric COVID-19 Severity Over the Course of the Pandemic
This cohort study suggested that while intensive care unit admission decreased over the course of the pandemic in all age groups, ventilatory and oxygen support did not decrease over time in children aged younger than 5 years.
